Scrip
International formulations business drives Lupin to 21% growth
29 July 2010
Anju Ghangurde
Please Login to read the full article.
29 July 2010
Anju Ghangurde
aghangurde@yahoo.com
Lupin has reported a 21% increase in net sales to Rs13.12 billion ($280.6 million) for the first quarter ended 30 June, led by strong growth in the formulations business in the US and Europe. Net profit rose by 40% to Rs1.96 billion.
US and Europe formulation sales increased by 40% to Rs4.96...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
FEATURES
- Anti-obesity drugs: an inventor's perspective
- Face-to-Face: Allon targets tau pathology with lead drug davunetide
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
